Skip to main content

Jim Cramer: Eli Lilly Hasn't Received Attention It Deserves

Publish date:
Video Rating:
Video Duration:

Eli Lilly's  (LLY)  antibody treatment, in a trial, was shown to cut the risk of COVID-19 by 80% for nursing home residents. 

Eli Lilly said the trial of the drug, bamlanivimab, involved 965 participants - 299 nursing home residents and 666 staff members -who tested negative for the coronavirus. They were given either an intravenous infusion of the drug or a placebo.

After eight weeks, the participants who had received bamlanivimab were 57% less likely to develop symptomatic Covid-19 than those who had received the placebo. 

Watch: Everything Jim Cramer is Watching in the Stock Market Thursday

Latest Videos From TheStreet and Jim Cramer:

Related Videos